[1]
M. Moussa, M. A. Chakra, B. Dabboucy, Y. Fares, A. Dellis, and A. Papatsoris, “The safety and effectiveness of mirabegron in Parkinson’s disease patients with overactive bladder: a randomized controlled trial”, SJU, vol. 56, no. 1, pp. 66–72, Jan. 2022.